One simple thing could prevent people using the ‘miracle’ drugs from sustaining long-term health consequences.
1don MSN
What obesity drugmakers see next in the market: More pills, easier access and drug combinations
CNBC spoke to executives from Eli Lilly, Novo Nordisk, Pfizer and other drugmakers at the annual JPMorgan Healthcare Conference in San Francisco.
The convenience and lower cost of the oral pill may be critical to some patients, which could expand the market, improve adherence and boost long-term outcomes.
This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Weight loss can be a challenge, even for those who eat healthily and exercise regularly. Injectable weight loss medications — also ...
Slimming injections cannot be sold or purchased in Hong Kong without doctor's prescription, but some retailers are operating grey market Online retailers and a Hong Kong pharmacy are offering slimming ...
Earlier this week, we learned about the deal between the White House and pharmaceutical companies to make those weight loss injections available at a much more affordable price starting in January.
As we step into 2026, the conversation around weight loss supplements is shifting. Gone are the days when prescription ...
This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Weight loss can be a challenge, even for those who eat healthily and exercise regularly. Injectable weight loss medications — also ...
Pharmacists urge patients to avoid buying the injections from beauty salons, unregulated sellers, an users with leftover pens ...
Discontinuing obesity medicines often means the weight comes back and people lose the cardiovascular and metabolic benefits ...
Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results